Has Ye Hu, MD received payments from drug or device companies?

Yes. Drug and device makers reported $20,364 in general payments to Ye Hu, MD across 36 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Ye Hu, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Ye Hu, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Ye Hu, MD

Neurology · Seattle, WANPI 1952729535

Payments from drug & device makers

$20,364in general payments, 2019–2025

Across 36 payments — averaging $565.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Roche Products Limited$20K
Novartis$188
Eisai Inc.$123
E.r. Squibb & Sons, L.L.C.$105
EMD Serono, Inc.$50
Biogen$40

$879in research payments, 2019–2025

Across 6 payments — averaging $146.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

AbbVie$879

What the payments were for

Food & beverage$505100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Roche Products Limited	29	$19,859
Novartis	2	$188
Eisai Inc.	1	$123
E.r. Squibb & Sons, L.L.C.	1	$105
EMD Serono, Inc.	1	$50
Biogen	2	$40

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Leqembi$123
ZEPOSIA$105

How this compares

$20,364 in reported general payments places this provider in the 80th percentile of 418 neurology providers in Washington.

See all neurology providers in Washington →

Medicare billing

Part B allowed, 2024

$66,750

Medicare patients

237

Services billed

744

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Kesimpta PenOfatumumab	26	$244,029
Teriflunomide	23	$20,509
Emgality PenGalcanezumab-Gnlm	18	$17,672
Dalfampridine ErDalfampridine	22	$8,615
Aimovig AutoinjectorErenumab-Aooe	11	$8,328
Rivastigmine	12	$2,799
Carbidopa-LevodopaCarbidopa/Levodopa	98	$2,594
Duloxetine Hcl	98	$2,501
Gabapentin	106	$2,457
Memantine Hcl	76	$2,280
Oxcarbazepine	21	$1,468
Baclofen	80	$1,341
Donepezil Hcl	105	$1,326
RivastigmineRivastigmine Tartrate	21	$1,193
Pregabalin	60	$1,172

Paid to pharmacies, not to this prescriber.

Other neurology in Seattle

Pavle RepovicSeattle$4.8M
Michael RosenbloomSeattle$1.8M
Michael WeissSeattle$936K
Suman JayadevSeattle$740K
Lucas McCarthySeattle$734K
Annette WundesSeattle$625K
Christyn EdmundsonSeattle$614K
Nathaniel WatsonSeattle$496K
Gloria von GeldernSeattle$441K
Pravin KhemaniSeattle$431K

See the full list for Washington →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →